Healthcare Services

Global Reproductive Genetics Market Expected to Reach $16.21 Billion by 2030 with 15.4% CAGR

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Reproductive Genetics Market During 2026–2030?

The reproductive genetics market size has seen rapid growth in recent years. It is forecast to expand from $7.91 billion in 2025 to $9.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. This historical growth can be linked to several factors, including an increase in assisted reproductive technologies usage, a rising maternal age at conception, the expansion of fertility clinics, greater awareness of inherited genetic disorders, and the availability of advanced molecular diagnostic tools.

The reproductive genetics market is projected for substantial growth over the next few years. It is expected to reach $16.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. This anticipated growth throughout the forecast period can be attributed to the increasing adoption of precision reproductive medicine, rising investments in fertility genomics research, the expansion of non-invasive prenatal testing, greater use of AI-driven genetic interpretation, and advancements in sequencing accuracy and affordability. Key trends for the forecast period include the increasing uptake of preimplantation genetic testing, a rising demand for carrier screening solutions, the growing application of NGS-based reproductive diagnostics, the expansion of personalized fertility treatment planning, and enhanced integration of laboratory automation.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28320&type=smp

What Underlying Factors Are Accelerating The Growth Of The Reproductive Genetics Market?

The rising incidence of genetic conditions is anticipated to drive the expansion of the reproductive genetics market in the future. Genetic disorders are defined as illnesses resulting from anomalies in an individual’s deoxyribonucleic acid (DNA), encompassing everything from singular gene mutations to chromosomal imperfections. This increase in genetic disorders is linked to the prevalence of reproductive genetic testing, as families pursue early information to minimize ambiguity, enable educated reproductive decisions, and aid in preventing the passing down of hereditary conditions. Reproductive genetics plays a crucial role in the detection and management of genetic conditions, assisting families in making well-informed choices and lowering the likelihood of transmitting these conditions to subsequent generations. An example illustrates this: in July 2024, Cystic Fibrosis Australia, a national consumer organization based in Australia, reported that the count of individuals affected by Cystic Fibrosis (CF) within the Australian Cystic Fibrosis Data Registry (ACFDR) climbed from 3,738 in 2022 to 3,798 in 2023, marking a 1.6% increase. Consequently, the growing occurrence of genetic conditions is projected to fuel the expansion of the reproductive genetics market.

How Are The Various Segments Of The Reproductive Genetics Market Categorized?

The reproductive genetics market covered in this report is segmented –

1) By Product Type: Kits, Laboratory Developed Tests (LDT), Reagents And Consumables

2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In-Situ Hybridization (ISH), Microarray Analysis

3) By Application: Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Other Applications

4) By End User: Hospitals, Diagnostic Laboratories, Fertility Clinics, Research Institutions

Subsegments:

1) By Kits: Sample Collection Kits, Extraction Kits, Amplification Kits, Sequencing Kits, Hybridization Kits

2) By Laboratory Developed Tests: Carrier Screening Tests, Preimplantation Genetic Tests, Prenatal Diagnostic Tests, Aneuploidy Detection Tests, Single Gene Disorder Tests

3) By Reagents And Consumables: Enzymes, Buffers, Probes, Fluorescent Labels, Laboratory Plasticware

How Are Trends Impacting The Reproductive Genetics Market?

Major companies in the reproductive genetics market are prioritizing the development of advanced solutions, such as comprehensive multi-trait embryo comparison, to enable more precise, data-driven, and personalized embryo selection for IVF patients. Comprehensive multi-trait embryo comparison describes an analytical approach that concurrently evaluates multiple embryos for hundreds of hereditary conditions and complex traits using genomic and polygenic scoring, assisting prospective parents in making more informed decisions during in vitro fertilization. For instance, in June 2025, Nucleus Genomics Inc., a US-based biotechnology company, launched Nucleus Embryo, a reproductive genetics platform. This platform allows patients to analyze and compare up to 20 embryos across more than 900 inherited conditions, incorporating polygenic scoring for complex traits such as appearance, cognitive ability, and mental health, and providing a comprehensive, multi-trait comparison interface that significantly expands embryo-selection capabilities beyond traditional screening methods.

Which Major Firms Influence Developments In The Reproductive Genetics Market?

Major companies operating in the reproductive genetics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Medicover AB, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., The Cooper Companies Inc., Vitrolife AB, BillionToOne Inc., Sophia Genetics SA, Eurofins Genomics India Private Limited, Invitae Corporation, Igenomix, Gonagen GmbH, Darwin AG.

Read the full reproductive genetics market report here:

https://www.thebusinessresearchcompany.com/report/reproductive-genetics-global-market-report

Which Region Is Projected To Dominate The Reproductive Genetics Market During The Forecast Period?

North America was the largest region in the reproductive genetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the reproductive genetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Reproductive Genetics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28320&type=smp

Browse Through More Reports Similar to the Global Reproductive Genetics Market 2026, By The Business Research Company

Genes Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Genotyping Assay Global Market Report

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Gene Expression Global Market Report

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795